Particulars |
|
|
|
Company Name
| Glenmark Life Sciences Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
24.51 |
B.V. (₹) |
190.30 |
Sales(₹ Cr.) |
2,283.21 |
NP (₹ Cr.) |
471.41 |
NP Var% |
1.00 |
Div% |
1,125.00 |
CPS(₹) |
42.80 |
EPS (₹) |
38.50 |
Traded Value(₹ Lakhs) |
58.28 |
52 Week High |
1,335.00 |
52 Week Low |
609.00 |
Price BSE |
1,111.00 |
Price NSE |
1,113.00 |
Market Capital (₹ Cr.) |
13,617.22 |
P/C Ratio |
25.90 |
P/E Ratio |
28.90 |
Price Vs.BV |
5.84 |
|
Latest Quarter |
Year End |
202406 |
Sales (₹ Cr.) |
588.62 |
NP(₹ Cr.) |
111.48 |
NP Var % |
-18.00 |
Trailing Twelve Months |
Year End |
202406 |
Sales |
2,035.73 |
OPM |
28.43 |
NP |
418.22 |
NP Var% |
-9.47 |
EPS |
36.47 |
PE |
30.47 |
|
|